Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury - Wikidata - awgldk - TriplyDB

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

http://www.wikidata.org/entity/Q58761997

about

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

http://www.wikidata.org/entity/Q58761997

description

article publié dans la revue scientifique Scientific Reports

@fr

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Scientific Reports

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@en

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@nl

type

label

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@en

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@nl

prefLabel

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@en

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@nl

P1433

Q58761997-82CAF501-1B45-4341-A681-6274063EE3F8

P1476

Q58761997-38ACE38F-F61B-4928-A811-6576BDF2D5B7

P2093

Q58761997-09414AA0-DECA-496F-886C-477428579A2C

Q58761997-213A6A0F-322B-4718-9F58-322ABB48DC89

Q58761997-3C58C381-AE2E-4FFC-A236-D48C702311CC

Q58761997-63AADB76-B150-4EDE-AA79-929EF9BF05EF

Q58761997-6DD0B53E-2B05-4D01-9E62-CDF1FEA001B7

Q58761997-94E75070-B111-400E-AB12-FA00147DAA4D

Q58761997-9C8D5EDF-DBBC-4AD6-9059-25E79B592249

Q58761997-AB2C9B39-7ACB-403C-95E6-F76A60731465

Q58761997-ACC12E62-6CA2-4D1F-9441-104C24BD9767

P2860

Q58761997-041EFDE7-E6C2-4428-9BE1-274CF01D2D44

Q58761997-045D1B93-CF7E-4385-B23D-FA3F96DED8E2

Q58761997-2504983E-5DF0-4D33-96C4-A90076DECAB9

Q58761997-26E5517C-E927-4934-89B6-BE22EEDB4879

Q58761997-273B133F-EEDC-451B-93BA-B95D3AAAEBB7

Q58761997-274616B0-B6C5-4CFD-9F15-74DFEC42633A

Q58761997-31A8B7C2-7E6B-4CD9-B95E-F6BBB68CDC1E

Q58761997-35E58E24-F035-4AAE-8849-E83C204BA009

Q58761997-3B6158D2-569F-4CF9-8498-85F8CE461F12

Q58761997-57EB394B-925E-4450-8B1E-F1DB6B2476F6

P304

Q58761997-D50A4CAD-1FE9-4FCD-A41C-7B461B389E69

P31

Q58761997-DC233C28-FBBF-43DC-8166-2654B651E6FF

P356

Q58761997-91296FD3-4CA0-4C55-93B4-777DB22EF6B7

P407

Q58761997-0DEDF6F1-8DF2-4973-B7C5-23C16E6CBA86

P433

Q58761997-C8DE3406-0122-4683-8549-0079F6A07661

P478

Q58761997-C2ACB8C7-E393-4E03-BDFA-2B89E4DD1720

P50

Q58761997-7ED0EE94-AFE4-4296-B5A3-92F591C29C6D

Q58761997-C9CCDA3A-19ED-4447-9CEB-A2C4FCBE086F

P577

Q58761997-21E8D8CE-5E7F-4E75-AD28-8702EB72DF6B

P698

Q58761997-EB331F91-2DC4-4507-8C57-8E0C06BA24D0

P932

Q58761997-A49579CE-316F-41DA-A3DE-86C200913306

P356

S41598-018-31846-Z

P1433

Scientific Reports

P1476

Imidazole Compounds for Protecting Choroidal Endothelial Cells from Complement Injury

@en

P2093

Edwin M Stone

http://www.w3.org/2001/XMLSchema#string

Grefachew Workalemahu

http://www.w3.org/2001/XMLSchema#string

Kathleen R Chirco

http://www.w3.org/2001/XMLSchema#string

Kuo-Kuang Wen

http://www.w3.org/2001/XMLSchema#string

Meng Wu

http://www.w3.org/2001/XMLSchema#string

Miles J Flamme-Wiese

http://www.w3.org/2001/XMLSchema#string

Robert F Mullins

http://www.w3.org/2001/XMLSchema#string

Shemin Zeng

http://www.w3.org/2001/XMLSchema#string

Xiuying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8

Ranibizumab and bevacizumab for neovascular age-related macular degeneration

A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays

Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial

Prevalence of age-related macular degeneration in the United States

Concerted regulation of retinal pigment epithelium basement membrane and barrier function by angiocrine factors.

A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.

Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration

Aurintricarboxylic acid inhibits complement activation, membrane attack complex, and choroidal neovascularization in a model of macular degeneration.

P304

13387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-31846-Z

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30190604

http://www.w3.org/2001/XMLSchema#string

P932

6127142

http://www.w3.org/2001/XMLSchema#string